Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

被引：0
|
作者：
Nakagawa, Hidemi [1 ]
Nemoto, Osamu [2 ]
Igarashi, Atsuyuki [3 ]
Saeki, Hidehisa
Kabashima, Kenji [4 ,5 ]
Oda, Manabu [6 ]
Nagata, Takeshi [6 ]
机构：
[1] Jikei Univ, Sch Med, Tokyo, Japan
[2] Kojinkai Sapporo Skin Clin, Tokyo, Japan
[3] NTT Med Ctr Tokyo, Dept Dermatol, Tokyo, Japan
[4] Nippon Med Sch, Dept Dermatol, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Dermatol, Tokyo, Japan
[6] Japan Tobacco Inc, Pharmaceut Div, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
25094
引用
收藏
页码：AB52 / AB52
页数：1
相关论文
共 50 条
  • [41] Pimecrolimus cream (1%) efficacy in perioral dermatitis -: results of a randomized, double-blind, vehicle-controlled study in 40 patients
    Oppel, T.
    Pavicic, T.
    Kamann, S.
    Braeutigam, M.
    Wollenberg, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 (09) : 1175 - 1180
  • [42] Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)
    Neve, Anuja
    Das, Bibha
    Wojtowicz, Jakub
    Huang, Zhiyue
    Bullain, Szofia
    Watkin, Michelle
    Lott, Dominik
    Bittner, Tobias
    Delmar, Paul
    Klein, Gregory
    Hofmann, Carsten
    Kerchner, Geoffrey A.
    Smith, Janice
    Baudler, Monika
    Fontoura, Paulo
    Doody, Rachelle S.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (01) : 353 - 367
  • [43] Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
    Seino, Yutaka
    Hiroi, Shinzo
    Hirayama, Masashi
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 517 - 525
  • [44] Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study
    Kaku, K.
    Itayasu, T.
    Hiroi, S.
    Hirayama, M.
    Seino, Y.
    DIABETES OBESITY & METABOLISM, 2011, 13 (11): : 1028 - 1035
  • [45] Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension
    Kadowaki, T.
    Kondo, K.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 418 - 425
  • [46] Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
    Seino, Y.
    Miyata, Y.
    Hiroi, S.
    Hirayama, M.
    Kaku, K.
    DIABETES OBESITY & METABOLISM, 2012, 14 (10): : 927 - 936
  • [47] Effective treatment of atopic dermatitis by cutaneous application of non-pathogenic bacteria Vitreoscilla filiformis ointment 5%:: Results from a randomized, double-blind, vehicle-controlled study
    Gueniche, A.
    Knaudt, B.
    Piche, E.
    Volz, T.
    Roecken, M.
    Biedermann, T.
    Bastien, P.
    Breton, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S18 - S18
  • [48] Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study
    Chung, Lorinda
    Silver, Richard M.
    Steen, Virginia
    Furst, Daniel E.
    Castelino, Flavia, V
    Trojanowski, Marcin
    Spiera, Robert
    Domsic, Robyn
    Rodriguez-Pla, Alicia
    Katsumoto, Tamiko R.
    Goulaouic, Helene
    Wang, Hong
    Espinasse, Melanie
    El-Chemaly, Souheil
    Wang, Rui
    RHEUMATOLOGY, 2025,
  • [49] Alogliptin plus voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension
    Seino, Yutaka
    Fujita, Tetsuya
    Hiroi, Shinzo
    Hirayama, Masashi
    Kaku, Kohei
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 : 21 - 29
  • [50] Topiramate in migraine prophylaxis: An open-label extension of a double-blind, placebo-controlled study
    Hart, DE
    Calder, CS
    Storey, JR
    Riback, P
    Potter, DL
    Wymer, JP
    Beesley, BA
    NEUROLOGY, 2002, 58 (07) : A496 - A497
12345